Literature DB >> 29650142

Endoscopic Approaches to Upper Tract Urothelial Carcinoma.

Firas G Petros1, Roger Li1, Surena F Matin2.   

Abstract

A select group of patients with upper tract urothelial carcinoma (UTUC) may meet indications for endoscopic management. Strategies for disease management are provided, based on a comprehensive review of the data using PubMed and Medline databases and marrying this with our experience with endoscopic management of UTUC. Endoscopic management of UTUC via retrograde or antegrade approaches is a viable treatment option for appropriately selected patients with low-risk UTUC, including those with low-grade, low-volume, and solitary tumors. However, recurrence risk limits these procedures to compliant patients under a vigilant surveillance program. Efficacious adjuvant therapies are needed to reduce local recurrences.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopy; Laser; Upper-tract urothelial carcinoma; Ureteral cancer; Ureteroscopy

Mesh:

Year:  2018        PMID: 29650142     DOI: 10.1016/j.ucl.2017.12.009

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

Review 1.  Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma.

Authors:  Firas G Petros
Journal:  Transl Androl Urol       Date:  2020-08

Review 2.  Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.

Authors:  Mudhar N Hasan; Morgan Rouprêt; Francis Keeley; Cecilia Cracco; Robert Jones; Michael Straub; Olivier Traxer; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

3.  Use of the T-1470 LiteTouch™ Laser in the En Bloc Resection of an Upper Tract Urothelial Cancer.

Authors:  Ezra Shoen; Benjamin Zollinger; Tripp Gresham; Katayoon M Rezaei; Michael Whalen
Journal:  Case Rep Urol       Date:  2021-01-26

Review 4.  Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.

Authors:  Hiroshi Fukushima; Baris Turkbey; Peter A Pinto; Aki Furusawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

5.  Cytotoxicity Assessment of a New Design for a Biodegradable Ureteral Mitomycin Drug-Eluting Stent in Urothelial Carcinoma Cell Culture.

Authors:  Federico Soria; Luna Martínez-Pla; Salvador D Aznar-Cervantes; Julia E de la Cruz; Tomás Fernández; Daniel Pérez-Fentes; Luis Llanes; Francisco Miguel Sánchez-Margallo
Journal:  Polymers (Basel)       Date:  2022-09-29       Impact factor: 4.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.